RDY Return On Equity from 2010 to 2025

RDY Stock  USD 13.46  0.25  1.82%   
Dr Reddys Return On Equity yearly trend continues to be fairly stable with very little volatility. Return On Equity will likely drop to 0.10 in 2025. Return On Equity is a measure of the profitability of Dr Reddys Laboratories in relation to the equity, calculated by dividing net income by shareholder's equity. View All Fundamentals
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
0.18
Current Value
0.1
Quarterly Volatility
0.06082335
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 2.1 B, Total Revenue of 337.1 B or Gross Profit of 197.6 B, as well as many indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0271 or PTB Ratio of 0.86. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.
  
Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Return On Equity Growth Pattern

Below is the plot of the Return On Equity of Dr Reddys Laboratories over the last few years. Return on Equity is the amount of Dr Reddys Laboratories net income returned as a percentage of Dr Reddys equity. Return on equity measures Dr Reddys profitability by revealing how much profit Dr Reddys Laboratories generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Dr Reddys' Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.1810 Years Trend
Very volatile
   Return On Equity   
       Timeline  

RDY Return On Equity Regression Statistics

Arithmetic Mean0.15
Geometric Mean0.13
Coefficient Of Variation41.70
Mean Deviation0.05
Median0.14
Standard Deviation0.06
Sample Variance0
Range0.2253
R-Value(0.07)
Mean Square Error0
R-Squared0.01
Significance0.78
Slope(0.0009)
Total Sum of Squares0.06

RDY Return On Equity History

2025 0.1
2024 0.18
2022 0.19
2021 0.12
2020 0.0985
2018 0.13
2017 0.0775

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Return On Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Equity 0.18  0.10 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.